Pieris Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Income Taxes (Tables)

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2015

(Loss) before income taxes consists of the following:


	Years Ended December 31,
	2015			2014
Domestic	$	(7,563,300	)	$	(1,235,446	)
Foreign		(6,291,475	)		(8,614,536	)

Loss before income taxes	$	(13,854,775	)	$	(9,849,982	)

Schedule of Components of Provision (Benefit) for Income Taxes

The components of the provision (benefit) for income taxes are as follows:


	Years Ended December 31,
	2015		2014
Current:
Federal	$	—	$	—
State		—		—
Foreign		203,866		(18	)

Total current		203,866		(18	)
Deferred:
Federal		—		—
State		—		—
Foreign		—		—

Total deferred		—		—

Provision (benefit) for income taxes	$	203,866	$	(18	)

Summary of Reconciliation of U.S. Statutory Rate to Company's Effective Tax Rate

The reconciliation of the federal statutory rate to Pieris’s effective tax rate is as follows:


	2015			2014
Federal income tax rate		34.0	%		34.0	%
Foreign rate differential		(2.1	)%		(4.3	)%
State tax, net of federal benefit		3.1			—
Permanent Items: Non-deductible expenses		(1.7	)		(4.5	)
Deferred adjustments		2.9			—
Loss of German NOL’s		(66.0	)		(74.2	)
Withholding tax		(1.5	)		—
Other		—			0.1

Change in valuation allowance		29.8			48.9

Effective income tax rate		(1.5	)%		0.0	%

Components of Deferred Tax Assets and Liabilities

The components of deferred tax assets and liabilities related to net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income taxes purposes were as follows:


	Years Ended December 31,
	2015			2014
Deferred tax assets:
Share based awards compensation	$	692,906		$	—
Accrued expenses		4,201			—
Book accumulated depreciation net of tax		12,276			—
Net operating loss carryforwards		4,147,012			9,951,666
Bank loan		—			12,653
Accrued compensation		129,624			—
Other		10,149			1,129

Total deferred tax assets		4,996,168			9,965,448
Less: valuation allowance:		(4,996,168	)		(9,916,553	)

Net deferred tax asset	$	—		$	48,895
Deferred tax liabilities:
Accrued expenses	$	—		$	(8,811	)
Prepaid expenses		—			(9,438	)
Depreciation		—			(30,646	)

Total deferred tax liabilities		—			(48,895	)

Net deferred taxes	$	—		$	—